NEXGEL (NXGL) Competitors $4.73 +0.11 (+2.38%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NXGL vs. SRTS, ZJYL, TLSI, TELA, GUTS, FONR, MGRM, ECOR, LNSR, and EDAPShould you be buying NEXGEL stock or one of its competitors? The main competitors of NEXGEL include Sensus Healthcare (SRTS), Jin Medical International (ZJYL), TriSalus Life Sciences (TLSI), TELA Bio (TELA), Fractyl Health (GUTS), FONAR (FONR), Monogram Orthopaedics (MGRM), electroCore (ECOR), LENSAR (LNSR), and Edap Tms (EDAP). These companies are all part of the "medical equipment" industry. NEXGEL vs. Sensus Healthcare Jin Medical International TriSalus Life Sciences TELA Bio Fractyl Health FONAR Monogram Orthopaedics electroCore LENSAR Edap Tms Sensus Healthcare (NASDAQ:SRTS) and NEXGEL (NASDAQ:NXGL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, community ranking, valuation and profitability. Which has better valuation & earnings, SRTS or NXGL? Sensus Healthcare has higher revenue and earnings than NEXGEL. NEXGEL is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensus Healthcare$41.31M2.82$490K$0.5712.46NEXGEL$6.73M4.77-$3.16M-$0.58-8.16 Does the media favor SRTS or NXGL? In the previous week, Sensus Healthcare had 1 more articles in the media than NEXGEL. MarketBeat recorded 1 mentions for Sensus Healthcare and 0 mentions for NEXGEL. Sensus Healthcare's average media sentiment score of 0.06 beat NEXGEL's score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media. Company Overall Sentiment Sensus Healthcare Neutral NEXGEL Neutral Do institutionals and insiders hold more shares of SRTS or NXGL? 25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 2.2% of NEXGEL shares are owned by institutional investors. 9.4% of Sensus Healthcare shares are owned by company insiders. Comparatively, 24.9% of NEXGEL shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts rate SRTS or NXGL? Sensus Healthcare currently has a consensus price target of $12.50, suggesting a potential upside of 76.06%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, research analysts clearly believe Sensus Healthcare is more favorable than NEXGEL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33NEXGEL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in SRTS or NXGL? Sensus Healthcare received 181 more outperform votes than NEXGEL when rated by MarketBeat users. Likewise, 68.42% of users gave Sensus Healthcare an outperform vote while only 50.00% of users gave NEXGEL an outperform vote. CompanyUnderperformOutperformSensus HealthcareOutperform Votes18268.42% Underperform Votes8431.58% NEXGELOutperform Votes150.00% Underperform Votes150.00% Which has more volatility and risk, SRTS or NXGL? Sensus Healthcare has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500. Comparatively, NEXGEL has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500. Is SRTS or NXGL more profitable? Sensus Healthcare has a net margin of 22.54% compared to NEXGEL's net margin of -52.60%. Sensus Healthcare's return on equity of 17.99% beat NEXGEL's return on equity.Company Net Margins Return on Equity Return on Assets Sensus Healthcare22.54% 17.99% 16.26% NEXGEL -52.60%-71.19%-34.79% SummarySensus Healthcare beats NEXGEL on 17 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get NEXGEL News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNEXGELSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$32.12M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E Ratio-8.1625.0190.0517.18Price / Sales4.7745.901,116.25117.05Price / CashN/A43.4443.1037.85Price / Book5.267.094.784.78Net Income-$3.16M$13.64M$120.31M$225.60M7 Day Performance0.42%-2.93%-1.92%-1.23%1 Month Performance42.47%-1.42%13.65%0.46%1 Year Performance110.22%39.20%28.34%15.24% NEXGEL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNEXGEL0.657 of 5 stars$4.73+2.4%N/A+122.1%$32.12M$6.73M-8.1610Positive NewsHigh Trading VolumeSRTSSensus Healthcare3.7704 of 5 stars$7.98-2.2%$12.50+56.6%+177.3%$130.79M$24.41M14.3240Positive NewsZJYLJin Medical InternationalN/A$0.78+0.3%N/A-98.8%$120.92M$19.82M0.00245Gap DownTLSITriSalus Life Sciences4.0193 of 5 stars$3.86-1.3%$12.08+213.0%-49.7%$117.70M$26.89M-1.57106Analyst ForecastInsider TradeNews CoveragePositive NewsGap UpTELATELA Bio2.9878 of 5 stars$2.82+1.8%$9.25+228.0%-53.6%$111.08M$58.45M-1.64120GUTSFractyl Health0.8734 of 5 stars$2.10+2.9%$22.00+947.6%N/A$101.01M$120,000.00-0.17102FONRFONARN/A$15.43-0.6%N/A-25.9%$97.64M$102.01M11.09480MGRMMonogram Orthopaedics3.2283 of 5 stars$2.80+5.3%$4.00+42.9%-23.1%$96.07M$364,999.00-5.6628Gap DownECORelectroCore2.6016 of 5 stars$14.44+6.1%N/A+161.0%$94.65M$23.33M-8.0750Analyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeLNSRLENSAR0.5735 of 5 stars$7.23-4.2%$8.00+10.7%+174.0%$83.98M$48.87M-5.17110News CoverageHigh Trading VolumeEDAPEdap Tms3.427 of 5 stars$2.22+0.9%$19.00+755.9%-57.0%$82.37M$63.41M-3.38307 Related Companies and Tools Related Companies SRTS Alternatives ZJYL Alternatives TLSI Alternatives TELA Alternatives GUTS Alternatives FONR Alternatives MGRM Alternatives ECOR Alternatives LNSR Alternatives EDAP Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NXGL) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NEXGEL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NXGL Stock Alerts